AVID BIOSERVICES INC. news, videos and press releases
For more news please use our advanced search feature.
AVID BIOSERVICES INC. - More news...
AVID BIOSERVICES INC. - More news...
- Avid Bioservices to Participate at Upcoming Investor Conferences
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
- Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
- Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
- Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
- Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility
- Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2024 After Market Close on September 7, 2023
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2023 After Market Close on June 21, 2023
- Avid Bioservices to Participate in RBC Capital Markets Global Healthcare Conference
- Avid Bioservices Unveils Completed Mammalian Cell Facilities Expansion Providing Significantly Increased Capacity for Existing and Future Customers
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2023, and Recent Developments
- Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2023 After Market Close on March 13, 2023
- Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2022 and Recent Developments
- Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2023 After Market Close on December 6, 2022
- Avid Bioservices Appoints Oksana Lukash as Vice President, People
- Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference
- Avid Bioservices to Participate in RBC Global CDMO Conference
- Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations
- Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
- Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments
- Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell Business
- Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022
- Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent Developments